Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates

Group 1: Earnings Performance - Delcath Systems, Inc. reported quarterly earnings of $0.05 per share, exceeding the Zacks Consensus Estimate of a loss of$ 0.10 per share, compared to a loss of $0.48 per share a year ago, representing an earnings surprise of 150% [1] - The company posted revenues of$ 15.1 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 33.04%, compared to year-ago revenues of $0.54 million [2] - Over the last four quarters, Delcath Systems has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Group 2: Stock Performance and Outlook - Delcath Systems shares have increased approximately 11.6% since the beginning of the year, while the S&P 500 has declined by 0.7% [3] - The current consensus EPS estimate for the coming quarter is -$ 0.17 on revenues of $11.9 million, and for the current fiscal year, it is -$ 0.41 on revenues of $62.3 million [7] - The estimate revisions trend for Delcath Systems is favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Group 3: Industry Context - The Medical - Instruments industry, to which Delcath Systems belongs, is currently in the top 34% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]